AFCG — Advanced Flower Capital Inc.

Summary of AFCG Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Quarterly Results:
  • Net interest income: $5.2 million
  • Distributable earnings: -$2.8 million (-$0.12 per share)
  • GAAP net income: $0.9 million ($0.04 per share)
• Full Year Results:
  • Net interest income: $24.6 million
  • Distributable earnings: $8.7 million ($0.39 per share)
  • GAAP net loss: -$20.7 million (-$0.95 per share)
• Portfolio Metrics:
  • Principal outstanding as of 12/31/2025: $317.4 million across 15 loans; increased to $366.4 million by 02/25/2026.
  • CECL reserve: $46.1 million (18.2% of loans at carrying value).
  • Total assets: $275.6 million; total shareholder equity: $175.6 million; book value per share: $7.46.
• Dividends: A first-quarter dividend of $0.05 per share declared, payable on 04/15/2026.

2. Strategic Updates and Business Highlights:

• The company focused on reducing exposure to underperforming credits and successfully converted from a REIT to a BDC on 01/01/2026, allowing for greater investment flexibility.
• Achieved $117 million in paydowns from loans, with $53 million in new commitments originated during 2025 and $89.7 million in new commitments closed post-year-end.
• The active deal pipeline has expanded to $1.4 billion, driven by the BDC conversion, allowing investments beyond real estate-backed loans.

3. Forward Guidance and Outlook:

• The company is optimistic about unlocking future earnings potential as it redeploys capital from repaid loans into performing credits.
• The first quarter's pace of loan originations is strong, but sustaining a $100 million quarterly pace may be challenging without further loan recoveries.
• Future dividends may continue to be characterized as a return of capital if additional losses are recognized in 2026.

4. Bad News, Challenges, or Points of Concern:

• The company reported realized losses from underperforming credits, impacting both quarterly and annual distributable earnings.
• Three loans are currently on nonaccrual status, with ongoing concerns about the recovery of principal from these loans.
• The regulatory landscape for cannabis loans remains uncertain, limiting new lending opportunities in that sector.
• The company faces challenges in the liquidation process for certain underperforming assets, which may affect cash flow and recovery timelines.

5. Notable Q&A Insights:

• The significant increase in the active pipeline is attributed to the BDC conversion, which has broadened the investment universe.
• Management is cautious about new cannabis loans due to regulatory hurdles and the industry's financial health.
• There is uncertainty regarding the recovery of principal from loans on nonaccrual, particularly for Private Company K and Justice Grown, with expectations of continued challenges in 2026.
• Management emphasized the importance of maintaining appropriate reserves and highlighted their focus on sourcing deals in the lower middle market.

Overall, while AFCG is navigating through challenges with underperforming loans, the strategic shift to a BDC structure and an expanding pipeline present opportunities for future growth. However, the company must address the risks associated with its legacy loans and the uncertain regulatory environment in the cannabis sector.